title: To oxidize or not to oxidize?
authors.forename: M B
authors.initials: MB
authors.lastname: Kastan
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D022762:CCAAT-Enhancer-Binding Proteins; D004268:DNA-Binding Proteins / Q000502:physiology*; D004317:Doxorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000494:pharmacology; D016193:G1 Phase; D006801:Humans; D009687:Nuclear Proteins / Q000502:physiology*; D010084:Oxidation-Reduction; D016283:Proto-Oncogene Proteins p21(ras) / Q000502:physiology*; D011759:Pyrrolidines / Q000494:pharmacology; D013859:Thiocarbamates / Q000494:pharmacology; D014157:Transcription Factors / Q000502:physiology*; D014407:Tumor Cells, Cultured; D014810:Vitamin E / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D000975:Antioxidants; D022762:CCAAT-Enhancer-Binding Proteins; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D011759:Pyrrolidines; D013859:Thiocarbamates; D014157:Transcription Factors; D014810:Vitamin E; C020972:pyrrolidine dithiocarbamic acid; D004317:Doxorubicin; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras); D005472:Fluorouracil